Neuroendocrine Disturbances in Huntington's Disease
Open Access
- 25 March 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (3) , e4962
Abstract
Huntington's disease (HD) is a severe inherited neurodegenerative disorder characterized, in addition to neurological impairment, by weight loss suggesting endocrine disturbances. The aims of this study were to look for neuroendocrine disturbances in patients with Huntington's disease (HD) and to determine the relationship with weight loss seen in HD We compared plasma levels of hormones from the five pituitary axes in 219 patients with genetically documented HD and in 71 sex- and age-matched controls. Relationships between hormone levels and disease severity, including weight-loss severity, were evaluated. Growth hormone (GH) and standard deviation score of insulin-like growth factor 1 (SDS IGF-1) were significantly higher in patients than in controls (0.25 (0.01–5.89) vs. 0.15 (0.005–4.89) ng/ml, p = 0.013 and 0.16±1.02 vs. 0.06±0.91, p = 0.039; respectively). Cortisol was higher (p = 0.002) in patients (399.14±160.5 nmol/L vs. 279.8±130.1 nmol/L), whereas no differences were found for other hormone axes. In patients, elevations in GH and IGF-1 and decreases in thyroid-stimulating hormone, free triiodothyronine and testosterone (in men) were associated with severity of impairments (Independence scale, Functional score, Total Functional Capacity, Total Motor score, Behavioral score). Only GH was independently associated with body mass index (β = −0.26, p = 0.001). Our data suggest that the thyrotropic and in men gonadotropic axes are altered in HD according to the severity of the disease. The somatotropic axis is overactive even in patients with early disease, and could be related to the weight loss seen in HD patients.Keywords
This publication has 42 references indexed in Scilit:
- Hypothalamic Dysfunction and Neuroendocrine and Metabolic Alterations in Huntington Disease: Clinical Consequences and Therapeutic ImplicationsReviews in the Neurosciences, 2007
- Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's diseaseEuropean Journal of Neuroscience, 2005
- Neuroendocrinology of Neurodegenerative DiseasesNeuroendocrinology, 2003
- Studies of hypothalamic function in Huntington's chorea.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Circadian rhythmicity of prolactin secretion in Huntington's ChoreaLife Sciences, 1980
- Growth hormone and prolactin secretion in Huntington's diseaseLife Sciences, 1979
- Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- PROLACTIN CONTROL IN HUNTINGTON'S CHOREAThe Lancet, 1977
- IMPAIRED PROLACTIN RELEASE IN HUNTINGTON'S CHOREAThe Lancet, 1977
- PATHOGENESIS OF HUNTINGTON'S CHOREAThe Lancet, 1973